Synchronous and Metachronous Metastatic Breast Cancer, with Different Histology and Opposite Immunophenotype, Treated with Combination of Chemotherapy, Anti-Her2, and Endocrine Therapy: A Case Report.

Autor:	Megaro, Giacomina, Rossi, Luigi, Ceddia, Serena, Sinjari, Marsela, Mannino, Adele, Gozzi, Elisa, Cosimati, Antonella, Brandi, Martina, Bitca, Victoria, Toscani, Ilaria, Cimino, Giuseppe, Tomao, Silverio
Předmět:	METASTATIC breast cancer HORMONE therapy COMBINATION drug therapy HORMONE receptor positive breast cancer BIOMARKERS BREAST cancer
Zdroj:	Case Reports in Oncology; 2020, Vol. 13 Issue 2, p544-549, 6p
Abstrakt:	In the case of our patient, the synergic action of endocrine therapy and chemotherapy plus dual anti-HER2 combination allowed a complete disease control. Therapy should be scheduled by considering the two cancers as individual entities. The approach to breast cancer is changing from being considered a singular disease to a multiform one, according to current research focused on biological markers such as HER2, ERs, and PRs, with important implications in clinical, prognostic, and therapeutic features. [ABSTRACT FROM AUTHOR]
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu Plný text ve formátu HTML
Nepřihlášeným uživatelům se plný text nezobrazuje	K zobrazení výsledku je třeba se přihlásit.